Rapport d’analyse de la taille, de la part et des tendances du marché des soins avancés des plaies en Asie-Pacifique – Aperçu et prévisions du secteur jusqu’en 2031

Analyse du marché des soins avancés des plaies en Asie-Pacifique

L'infection des plaies affecte la qualité de vie du patient et exige donc une méthode de cicatrisation efficace. Il existe plusieurs types de méthodes de cicatrisation des plaies, notamment les pansements, les produits biologiques comme les allogreffes, les greffes synthétiques et les dispositifs thérapeutiques, entre autres. L'incidence croissante du diabète et des plaies chroniques associées ainsi que le nombre croissant de patients subissant des interventions chirurgicales assurent au marché une croissance lucrative. Un autre facteur qui stimule la croissance du marché est le progrès technologique dans le traitement des plaies.

Taille du marché des soins avancés des plaies en Asie-Pacifique

La taille du marché des soins avancés des plaies en Asie-Pacifique était évaluée à 2,53 milliards USD en 2023 et devrait atteindre 4,41 milliards USD d'ici 2031, avec un TCAC de 7,2 % au cours de la période de prévision de 2024 à 2031.

Portée du rapport et segmentation du marché       

Définition du marché des soins avancés des plaies en Asie-Pacifique

Wounds are defined as the breakdown of any protective function of the skin with or without the loss of the underlying connective tissue. Wounds are formed due to several reasons, including cuts, chemical exposure, friction, shear force, and diseases, among others. There are several kinds of wounds depending upon the severity and nature, including class I, class II, class III, and class IV. Wounds can be treated as primary or secondary intention depending upon the close or open wounds, among others.

Advanced Wound Care Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail as below:

Drivers

• Increasing Cases of Chronic Wounds

Rapidly growing incidence of diabetes and chronic wounds is a major factor contributing to the growth of this market. Chronic diseases are among the most predominant and expensive health situations worldwide. Chronic diseases include diabetes, cancer, stroke, heart disease, hypertension, arthritis, respiratory diseases, oral diseases, and obesity. These can lead to long-term disability and hospitalization, which may reduce the quality of life and, ultimately, death.

In some parts of New Zealand, the rising incidence of early occurrence of type 2 diabetes is seen in many people. This has a certain risk of early death coupled with complications, including problems related to cardiac health. Some of the reasons responsible for the occurrence of chronic wounds such as the growing aging population and the increasing prevalence of diseases like overweight, hypertension, and the late side effects of radiation therapy.

For instance,

• According to IDF Diabetes Atlas, it is estimated that more than 96,000 children and adolescents under the age of 15 are diagnosed with type 1 diabetes every year, and 132,600 when the age number exceeds 20 years.

Chronic diseases are rapidly increasing day by day in many countries, and the Asia-Pacific accounts for the most number of cases of chronic diseases. The average suffering rate due to chronic disease is 7 out of 10 people, and increasing prevalence of chronic wounds such as diabetic ulcers and foot ulcers. Hence they need to go for various surgeries. Thus, the rising incidence of diabetes and associated chronic wounds will have an impact on the advanced wound care market, which will propel the market in the futuristic period.

• New Product Launches

Conventional wound care products are replaced with advanced wound care products due to their increased efficacy and effectiveness in managing wounds by offering rapid healing. The companies, including B. Braun Melsungen AG, Coloplast Group, and Integra LifeSciences, among others, are taking initiatives to launch new products with advanced technologies.

For instance,

• In May 2020, Integra LifeSciences announced a positive clinical result for Integra Bilayer Wound Matrix (IBWM). This product is part of the company’s regenerative technology portfolio, which uses collagen and amniotic products.

To attract more customers and to create new marketing opportunities for growing companies engaged in advanced wound care, healthcare professionals and researchers are developing new and innovative products, and this leads to the growth of the advanced wound care market.

• Increasing Number of Patients Undergoing Surgical Procedures

According to National Center for Biotechnology Information, wound infection is an important issue observed in surgical sections. The cause of infection is associated with the patient and their disease. Also, the wound infection depends on age, gender, contamination of the wound, time and type of operation and anesthesia, hospitalization duration, and wound drainage.

As per National Center for Biotechnology Information, approximately 6.5 million patients are affected by chronic wounds. It is estimated that more than USD 25 billion is spent per year on the treatment of chronic wounds. This is tremendously increasing due to the rising aging population, healthcare expenses, and diabetic and obese population in the Asia-Pacific region.

About 72% of patients with pressure ulcers at the age of 65 years underwent surgery. Among those hospitalized patients, about 9 out of 10 were covered by government health programs, in which around 66% and 23% were covered by Medicare state and Medicaid programs, respectively. Patients diagnosed with pressure ulcers are generally admitted to the hospital for medical reasons rather than pressure ulcers. The pressure ulcer patients are diagnosed with pneumonia, urinary tract infections (UTI), septicemia, respiratory failure, congestive heart failure (CHF), and critical diabetes mellitus (DM). The number of hospital patients who develop pressure ulcers has increased by approximately 63% in the last decade.

Opportunities

• Growth Potential in Emerging Economies

For the wound care practitioner, the most advanced dressings in developing countries are important. These materials are made of a wide range of products such as polyurethane, alginic acid salts, and other polysaccharides that are gelable; these products are used in wound care in developed countries. The circumstances are different in developing economies where traditional agents such as chlorhexidine, sodium hypochlorite, cetrimide, hydrogen-peroxide, and others are commonly available to wound care providers. Wound healing is an important process, and as the wound moves towards healing, the quality specification of a dressing increases.

For instance,

• According to World Health Organization, approximately 400 million people worldwide are dealing with diabetes. In developing countries, the age of diabetes is 45–64. By 2030, developing countries are predicted to have more people with diabetes, about 82 million of which are 65 years of age, than developed countries (48 million). The diabetic population has at a major risk of foot ulcers. Thus, this will directly affect on advanced wound care.

China's increasing technological advancement involves the treatment of wound care for better products and dressings to widen the market. The aging population of China is becoming increasingly prone to chronic, unhealing wounds due to complications such as cardiovascular diseases, obesity, and diabetes. In rural areas with poor access to health care, traditional treatments such as sutures, specialized wound dressings, and tools for wound debriding tend to gain acceptance. Many patients from all over the world are heading to countries in Asia-Pacific to get medical treatment as they need to save the expenditures on treatments. India and Thailand are the top destinations for medical tourism. Cost is often a highly concerning reason that patients are traveling for medical treatment.

• According to an article published in IJITEE, India is one of the major countries in medical tourism compared to other countries. Patients are enthusiastically approaching India because of prices, weather, community, and holidays. , The arrival of foreign tourists in India for medical treatment in the year 2015 is more than 7101.9. The annual growth rate is around 30%, and the profits earned at the end of 2015 were around USD 1482 million. Because of economic health services, 150,000 customers travel to India each year.

In various developing economies, treatable wounds and medical tourism are the major reasons for the development of advanced wound care. Most of the advanced dressings need to be available in the market in developing countries for wound care. New technologies and products for wound care are introduced in developing countries. Thus, this will help to maximize the growth of the advanced wound care market in developing countries.

Restraints/Challenges

However, the barriers to advanced wound care techniques and the high cost of the treatment process in some regions may impede the growth of advanced wound care, which is hampering the growth of the market. Additionally, high competition in medical technology industries and long lead time for the overseas qualification can be challenging factors for the growth of the market

This advanced wound care market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lung cancer surgery market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you to make an informed market decision to achieve market growth.

Asia-Pacific Advanced Wound Care Market Scope

Asia-Pacific advanced wound care market is segmented into product type, wound type, wound class, end user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product Type

• Dressing
• Biologics
• Therapy Devices
• Others

Wound Class

• Class I
• Class II
• Class III
• Class IV

Wound Care

• Primary Wound Care
• Secondary Wound Care

End User

• Hospitals
• Wound Care Centers
• Ambulatory Centers
• Home Healthcare
• Clinics
• Others

Distribution Channel

• Direct Tender
• Retail

Advanced Wound Care Market Regional Analysis

The advanced wound care market is analysed, and market size insights and trends are provided by country, product type, wound type, wound class, end user, and distribution channels, as referenced above.

Countries covered in Asia-Pacific advanced wound care market are Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines and Rest of the Asia-Pacific.

Japan dominates the Asia-Pacific advanced wound care market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the rising need for the verification and validation of wound care treatment processes in the region, and rapid research development is boosting the market

The country section of the report also provides individual market-impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.

Advanced Wound Care Market Share

Le paysage concurrentiel du marché des soins avancés des plaies fournit des détails par concurrents. Les détails comprennent un aperçu de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit et la domination des applications. Les points de données ci-dessus fournis ne concernent que les entreprises se concentrant sur le marché des soins avancés des plaies.

Les leaders du marché des soins avancés des plaies opérant sur le marché sont :

• Smith et Neveu
• 3M
• Medline Industries, Inc.
• Mölnlycke Health Care AB
• ConvaTec Inc
• Baxter
• Santé cardinale
• Groupe L&R
• HARTMANN USA, Inc. (Une filiale de PAUL HARTMANN AG)
• MiMedx
• Johnson & Johnson Services, Inc.
• Société Integra LifeSciences
• Groupe Coloplast
• B. Braun Melsungen AG
• Medtronic, Hollister Incorporated
• Zimmer Biomet
• Elkem Silicones (Une filiale de China National Bluestar (Group) Co, Ltd.)

Dernières avancées en matière de soins avancés des plaies

• En août 2020, Medline Industries, Inc. a étendu ses activités en étendant ses services dans la région du Nord-Est. La société a ouvert un nouveau centre de distribution de produits à Uxbridge, dans le Massachusetts. Cette initiative a amélioré le réseau de distribution de produits de la société et lui a permis de générer davantage de revenus sur le marché des soins avancés des plaies.
• En février 2020, Baxter a acquis Seprafilm Adhesion Barrier auprès de Sanofi. Le produit acquis est utilisé comme adjuvant afin de réduire la gravité des adhérences dans le cas de chirurgies abdominales et de certaines chirurgies pelviennes. Cette acquisition a permis à l'entreprise de pénétrer le marché des soins avancés des plaies.

SKU-1514